Please wait while the formulary information is being retrieved.
AFINITOR (EVEROLIMUS)
- Er(+), HEr2(-) postmenopausal advanced breast cancer
- Metastatic renal cell carcinoma
- Pancreatic neuroendocrine tumor
- Nonfunctional neuroendocrine tumor of GI origin
- Nonfunctional neuroendocrine tumor of lung origin
- Renal angiomyolipoma with tuberous sclerosis complex
- SEGA associated with tuberous sclerosis
10 mg tablet
- 1 tablet (10 mg) by oral route once daily
2.5 mg tablet
- 1 tablet (2.5 mg) by oral route once daily
5 mg tablet
- 2 tablets (10 mg) by oral route once daily
7.5 mg tablet
- 1 tablet (7.5 mg) by oral route once daily swallowing whole witha glass of water. Do not crush, chew and/or divide.
Er(+), HEr2(-) postmenopausal advanced breast cancer
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
Metastatic renal cell carcinoma
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
Nonfunctional neuroendocrine tumor of GI origin
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
Nonfunctional neuroendocrine tumor of lung origin
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
Pancreatic neuroendocrine tumor
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
Renal angiomyolipoma with tuberous sclerosis complex
- 1 tablet (5 mg) by oral route once daily
- 2 tablets (10 mg) by oral route once daily
- 1 tablet (10 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
SEGA associated with tuberous sclerosis
- 4.5 mg/m2 by oral route once daily
- 1 tablet (7.5 mg) by oral route once daily swallowing whole witha glass of water. Do not crush, chew and/or divide.
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- Alagesic Lq
- amobarbital
- amoxicil-clarithromy-lansopraz
- Amytal
- Ascomp With Codeine
- atazanavir
- B cplx-C-St.Johnwrt-K.&S.ginsg
- Belladonna-phenobarbital
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- boceprevir
- Bupap
- butabarbital
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-acetaminop-caf-cod
- butalbital-acetaminophen
- butalbital-acetaminophen-caff
- butalbital-aspirin-caffeine
- Butisol
- calcium-mag-B complex-D3-hrb61
- Capacet
- carbamazepine
- Carbatrol
- Cerebyx
- clarithromycin
- clozapine
- Clozaril
- codeine-butalbital-ASA-caff
- Cold & Flu Fighter
- conivaptan in 5 % dextrose
- Crixivan
- cyclosporine
- cyclosporine modified
- deferiprone
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Donnatal
- elvitegr-cobicist-emtric-tenof
- Epitol
- Equetro
- Esgic
- ethotoin
- Fatigue Relief Complex
- Fazaclo
- Ferriprox
- Fioricet
- Fioricet With Codeine
- Fiorinal
- Fiorinal-codeine #3
- fosphenytoin
- Gengraf
- Incivek
- indinavir
- Invirase
- isoniazid-rifamp-pyrazinamide
- itraconazole
- Kaletra
- Ketek
- ketoconazole
- lopinavir-ritonavir
- Luminal
- Margesic
- Marten-tab
- Mycobutin
- Mysoline
- nafcillin
- nafcillin in dextrose iso-osm
- nefazodone
- nelfinavir
- Nembutal Sodium
- Neoral
- Norvir
- Norvir Soft Gelatin
- Noxafil
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Onmel
- Peganone
- pentobarbital sodium
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- posaconazole
- Prevpac
- Priftin
- primidone
- Reyataz
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- ritonavir
- Sandimmune
- saquinavir mesylate
- secobarbital sodium
- Seconal Sodium
- Sporanox
- Sporanox Pulsepak
- St. John's wort
- Stribild
- Tegretol
- Tegretol Xr
- telaprevir
- telithromycin
- Tencon
- Vaprisol
- Versacloz
- Vfend
- Vfend Iv
- Victrelis
- Viracept
- vit C-St. John wort-elder-hb30
- voriconazole
- Women's Complex
- Zebutal
Severe
Moderate
- Advil
- Advil Allergy Sinus
- Advil Allergy-congestion Rlf
- Advil Cold & Sinus
- Advil Congestion Relief
- Advil Liqui-gel
- Advil Migraine
- Advil Pm
- Advil Pm Liqui-gels
- Aleve
- Aleve Cold & Sinus
- Aleve Sinus & Headache
- Aleve-d Sinus & Cold
- Aleve-d Sinus & Headache
- All Day Pain Relief
- All Day Pain Relief Sinus & Co
- All Day Relief
- Anaprox
- Anaprox Ds
- Ansaid
- aprepitant
- Arthrotec 50
- Calan
- Calan Sr
- Caldolor
- Cambia
- Cardizem
- Cardizem Cd
- Cardizem La
- Cartia Xt
- Cataflam
- Child Ibuprofen
- Children's Advil
- Children's Ibu-drops
- Children's Ibuprofen
- Children's Medi-profen
- Children's Motrin
- Children's Profen Ib
- chlorphen-phenyleph-ibuprofen
- chlorphen-pseudoeph-ibuprofen
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- Cold & Sinus Pain Relief
- Cold-sinus Relief
- crizotinib
- darunavir
- Daypro
- delavirdine
- diclofenac epolamine
- diclofenac potassium
- diclofenac sodium
- diclofenac submicronized
- diclofenac-misoprostol
- Diflucan
- Dilacor Xr
- Dilt-xr
- diltiazem HCl
- Duexis
- Ec-naprosyn
- Emend
- Erythrocin
- erythromycin
- erythromycin-sulfisoxazole
- etodolac
- Feldene
- fenoprofen
- Flanax
- Flector
- fluconazole
- fluconazole in dextrose(iso-o)
- fluconazole in NaCl (iso-osm)
- flurbiprofen
- fosamprenavir
- fosaprepitant
- Gleevec
- hydrocodone-ibuprofen
- I-prin
- Ibu-drops
- Ibudone
- ibuprofen
- Ibuprofen Cold
- Ibuprofen Cold-sinus(with Pse)
- Ibuprofen Ib
- Ibuprofen Jr Strength
- ibuprofen lysine (PF)
- Ibuprofen Pm
- ibuprofen-diphenhydramine
- ibuprofen-diphenhydramine HCl
- ibuprofen-famotidine
- ibuprofen-oxycodone
- ibuprofen-phenylephrine HCl
- imatinib
- Indocin
- indomethacin
- indomethacin sodium
- Infant's Ibuprofen
- Infant's Medi-profen
- Infant's Motrin
- Infants Ibu-drops
- Infants Profenib
- Juxtapid
- ketoprofen
- ketorolac
- Lexiva
- lomitapide
- Matzim La
- Medi-profen
- Mediproxen
- mefenamic acid
- Midol (naproxen)
- Motrin Ib
- Motrin Pm
- nabumetone
- Nalfon
- Naprelan Cr
- Naprosyn
- naproxen
- naproxen sodium
- naproxen-esomeprazole
- naproxen-pseudoephedrine
- Neoprofen (ibuprofen Lysn)(pf)
- oxaprozin
- Pennsaid
- piroxicam
- Ponstel
- Prezista
- Provil
- pseudoephedrine-ibuprofen
- Reprexain
- Rescriptor
- Sinus & Cold-d
- Solaraze
- Sprix
- sulindac
- Tarka
- Taztia Xt
- Tiazac
- tolmetin
- trandolapril-verapamil
- verapamil
- Verelan
- Verelan Pm
- Vicoprofen
- Vimovo
- Voltaren-xr
- Wal-profen
- Wal-profen Cold-sinus
- Wal-proxen
- Xalkori
- Zipsor
- Zorvolex
- Lactating mother
Contraindicated
- Acute renal failure
- Disease of liver
- Interstitial pneumonitis
- Pleural effusions
- Pregnancy
- Reactivation of hepatitis B
- Severe infection
- Stomatitis
Severe
Moderate
- Anemia
- Diabetes mellitus
- Edema
- Hyperlipidemia
- Impaired wound healing
- Leukopenia
- Neutropenic disorder
- Perioperative care
- Proteinuria
- Thrombocytopenic disorder
AFINITOR (EVEROLIMUS)
- Er(+), HEr2(-) postmenopausal advanced breast cancer
- Metastatic renal cell carcinoma
- Pancreatic neuroendocrine tumor
- Nonfunctional neuroendocrine tumor of GI origin
- Nonfunctional neuroendocrine tumor of lung origin
- Renal angiomyolipoma with tuberous sclerosis complex
- SEGA associated with tuberous sclerosis
- Abnormal hepatic function tests
- Anemia
- Dyspnea
- Hyperglycemia
- Hypophosphatemia
- Infection
- Neutropenic disorder
- Paresthesia
- Peripheral edema
- Pneumonia
- Thrombocytopenic disorder
- Acne vulgaris
- Acute abdominal pain
- Anorexia
- Aphthous stomatitis
- Arthralgias
- Cough
- Diarrhea
- Dysgeusia
- Epistaxis
- Fatigue
- Fever
- Headache disorder
- Lymphopenia
- Nail disorders
- Nausea
- Sinusitis
- Skin rash
- Sore throat
- Stomatitis
- Symptoms of anxiety
- Upper respiratory infection
- Vomiting
- Weight loss
More Frequent
Severe
Less Severe
- Candidiasis
- Dehydration
- Depression
- Diabetes mellitus
- Hemorrhage
- Hypersensitivity pneumonitis
- Hypertension
- Hypokalemia
- Interstitial pneumonitis
- Palmar-plantar erythrodysesthesia
- Pleural effusions
- Abnormal vaginal bleeding
- Acute bacterial otitis media
- Aggressive behavior
- Alopecia
- Amenorrhea
- Back pain
- Cellulitis
- Chest pain
- Chills
- Constipation
- Dizziness
- Dry skin
- Dysphagia
- Edema
- Eyelid edema
- Flushing
- Follicle-stimulating hormone hypersecretion
- General weakness
- Hemorrhoids
- Hyperlipidemia
- Hypertriglyceridemia
- Insomnia
- Jaw pain
- Luteinizing hormone hypersecretion
- Menstrual disorder
- Mouth irritation
- Muscle spasm
- Onychoclasis
- Ovarian cyst
- Proteinuria
- Pruritus of skin
- Rhinorrhea
- Urinary tract infection
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute pancreatitis
- Acute renal failure
- Acute respiratory distress syndrome
- Anaphylaxis
- Angioedema
- Arterial thrombosis
- Bacterial sepsis
- Biliary calculus
- Cholecystitis
- Complex regional pain syndrome, type I
- Deep venous thrombosis
- Fungal sepsis
- Heart failure
- Impaired wound healing
- Interstitial lung disease
- Malignant lymphoma
- Malignant neoplasm of skin
- Mycobacteriosis
- Opportunistic fungal infection
- Pneumocystis jirovecii pneumonia
- Post kidney transplant renal thrombosis
- Protozoal infection
- Pulmonary hypertension
- Pulmonary thromboembolism
- Reactivation of hepatitis B
- Thrombotic disorder
- Viral infection
Less Severe
- Azoospermia
Contraindicated
None
Severe Precaution
Everolimus (antineoplastic)
Approved only for Tuberous Sclerosis- associated subependymal giant cell astrocytoma (SEGA) age >1 year, TS-associated partial onset seizure age > 2 years. Risk of severe infection.
Increased risk of infection age < 6 years. Indicated only for tuberous sclerosis associated SEGA and partial-onset seizures.
- 1 Day – 364 Days
- Approved only for Tuberous Sclerosis- associated subependymal giant cell astrocytoma (SEGA) age >1 year, TS-associated partial onset seizure age > 2 years. Risk of severe infection.
- Increased risk of infection age < 6 years. Indicated only for tuberous sclerosis associated SEGA and partial-onset seizures.
- 1 Years – 6 Years
- Approved only for Tuberous Sclerosis- associated subependymal giant cell astrocytoma (SEGA) age >1 year, TS-associated partial onset seizure age > 2 years. Risk of severe infection.
- Increased risk of infection age < 6 years. Indicated only for tuberous sclerosis associated SEGA and partial-onset seizures.
Management or Monitoring Precaution
None
Everolimus
- Severity Level:
D
- Additional Notes: Potential for fetal harm based on drug pharmacology; animal data sugg dev tox
Contraindicated
Everolimus
Potential for adv effects; avoid during nursing and 2 wks after last dose
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Potential for adv effects; avoid during nursing and 2 wks after last dose |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Everolimus
General-The incidence of deaths due to any cause within 28 days of the last everolimus dose was 6% in patients greater than or equal to 65 years of age compared to 2% in patients less than 65 years.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | N | N | N | Y |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Er(+), HEr2(-) postmenopausal advanced breast cancer | |
| C50.11 | Malignant neoplasm of central portion of breast, female |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.61 | Malignant neoplasm of axillary tail of breast, female |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.81 | Malignant neoplasm of overlapping sites of breast, female |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.91 | Malignant neoplasm of breast of unspecified site, female |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| Z17.0 | Estrogen receptor positive status [Er+] |
| Metastatic renal cell carcinoma | |
| C64 | Malignant neoplasm of kidney, except renal pelvis |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis |
| Nonfunctional neuroendocrine tumor of GI origin | |
| C7A.01 | Malignant carcinoid tumors of the small intestine |
| C7A.010 | Malignant carcinoid tumor of the duodenum |
| C7A.011 | Malignant carcinoid tumor of the jejunum |
| C7A.012 | Malignant carcinoid tumor of the ileum |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion |
| C7A.02 | Malignant carcinoid tumors of the appendix, large intestine, and rectum |
| C7A.020 | Malignant carcinoid tumor of the appendix |
| C7A.021 | Malignant carcinoid tumor of the cecum |
| C7A.022 | Malignant carcinoid tumor of the ascending colon |
| C7A.023 | Malignant carcinoid tumor of the transverse colon |
| C7A.024 | Malignant carcinoid tumor of the descending colon |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon |
| C7A.026 | Malignant carcinoid tumor of the rectum |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion |
| C7A.092 | Malignant carcinoid tumor of the stomach |
| C7A.094 | Malignant carcinoid tumor of the foregut, unspecified |
| C7A.095 | Malignant carcinoid tumor of the midgut, unspecified |
| C7A.096 | Malignant carcinoid tumor of the hindgut, unspecified |
| Nonfunctional neuroendocrine tumor of lung origin | |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung |
| Pancreatic neuroendocrine tumor | |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| Renal angiomyolipoma with tuberous sclerosis complex | |
| D30.0 | Benign neoplasm of kidney |
| D30.00 | Benign neoplasm of unspecified kidney |
| D30.01 | Benign neoplasm of right kidney |
| D30.02 | Benign neoplasm of left kidney |
| SEGA associated with tuberous sclerosis | |
| D33.0 | Benign neoplasm of brain, supratentorial |
| D33.1 | Benign neoplasm of brain, infratentorial |
| D33.2 | Benign neoplasm of brain, unspecified |
| 0-9 | A-Z |
|---|---|
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C50.11 | Malignant neoplasm of central portion of breast, female |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.61 | Malignant neoplasm of axillary tail of breast, female |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.81 | Malignant neoplasm of overlapping sites of breast, female |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.91 | Malignant neoplasm of breast of unspecified site, female |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C64 | Malignant neoplasm of kidney, except renal pelvis |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis |
| C7A.01 | Malignant carcinoid tumors of the small intestine |
| C7A.010 | Malignant carcinoid tumor of the duodenum |
| C7A.011 | Malignant carcinoid tumor of the jejunum |
| C7A.012 | Malignant carcinoid tumor of the ileum |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion |
| C7A.02 | Malignant carcinoid tumors of the appendix, large intestine, and rectum |
| C7A.020 | Malignant carcinoid tumor of the appendix |
| C7A.021 | Malignant carcinoid tumor of the cecum |
| C7A.022 | Malignant carcinoid tumor of the ascending colon |
| C7A.023 | Malignant carcinoid tumor of the transverse colon |
| C7A.024 | Malignant carcinoid tumor of the descending colon |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon |
| C7A.026 | Malignant carcinoid tumor of the rectum |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung |
| C7A.092 | Malignant carcinoid tumor of the stomach |
| C7A.094 | Malignant carcinoid tumor of the foregut, unspecified |
| C7A.095 | Malignant carcinoid tumor of the midgut, unspecified |
| C7A.096 | Malignant carcinoid tumor of the hindgut, unspecified |
| D30.0 | Benign neoplasm of kidney |
| D30.00 | Benign neoplasm of unspecified kidney |
| D30.01 | Benign neoplasm of right kidney |
| D30.02 | Benign neoplasm of left kidney |
| D33.0 | Benign neoplasm of brain, supratentorial |
| D33.1 | Benign neoplasm of brain, infratentorial |
| D33.2 | Benign neoplasm of brain, unspecified |
| Z17.0 | Estrogen receptor positive status [Er+] |
Formulary Reference Tool